SMYD2 promotes cervical cancer growth by stimulating cell proliferation

Abstract Background Cervical cancer is the most common gynecological malignancy with low terminal cure rate, and therefore new therapeutic targets are urgently needed to combat this disease. SMYD2, as an oncogene, is abnormal highly expressed in multiple types of tumors and further affects the occur...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Jun-Jie Sun, Hong-Lin Li, Hui Ma, Yang Shi, Li-Rong Yin, Su-Jie Guo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMC 2019-09-01
coleção:	Cell & Bioscience
Assuntos:	Cervical cancer SMYD2 Prognosis Proliferation Therapeutic target
Acesso em linha:	http://link.springer.com/article/10.1186/s13578-019-0340-9
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!